The tumor was hormone receptor-negative for Progesterone Receptor (PR-) but tested positive for Estrogen Receptor (ER+) and Human Epidermal Growth Factor Receptor 2 (HER2+) (Figure 1C). This evidence concerns the gene ERBB2 and neoplasm.